Ampio Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ampio Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Ampio Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $56.4M, a 3.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $56.4M +$2.01M +3.7% Dec 31, 2023 10-K 2024-03-27
Q4 2022 $54.4M +$4.26M +8.5% Dec 31, 2022 10-K 2024-03-27
Q4 2021 $50.1M +$4.56M +10% Dec 31, 2021 10-K 2023-03-27
Q4 2020 $45.6M +$2.89M +6.77% Dec 31, 2020 10-K 2022-03-29
Q4 2019 $42.7M +$3.8M +9.76% Dec 31, 2019 10-K 2021-03-03
Q4 2018 $38.9M Dec 31, 2018 10-K 2020-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.